Hepatocellular Carcinoma
eBook - PDF

Hepatocellular Carcinoma

Future Outlook

Ahmed O. Kaseb

  1. 332 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Hepatocellular Carcinoma

Future Outlook

Ahmed O. Kaseb

Book details
Table of contents
Citations

About This Book

Hepatocellular carcinoma (HCC) develops as a consequence of underlying chronic liver disease, most commonly cirrhosis. Therefore, HCC management draws on the expertise of a range of medical specialists. Many components of current novel therapeutic modalities for HCC are discussed in the current version of the book within the framework of a multidisciplinary approach with special emphasis on emerging treatment approaches and research strategies. This book is the essential clinical guide for oncologists, hepatologists, surgeons, and all physicians and researchers involved in the care of patients with HCC. I would like to thank the authors for their significant efforts in bringing this edition to life. This book is a tribute to their continued dedication to improving HCC outcome.

Frequently asked questions

How do I cancel my subscription?
Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
Can/how do I download books?
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
What is the difference between the pricing plans?
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
What is Perlego?
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Do you support text-to-speech?
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Is Hepatocellular Carcinoma an online PDF/ePUB?
Yes, you can access Hepatocellular Carcinoma by Ahmed O. Kaseb in PDF and/or ePUB format, as well as other popular books in Médecine & Oncologie. We have over one million books available in our catalogue for you to explore.

Information

Publisher
IntechOpen
Year
2013
ISBN
9789535171836
Topic
Médecine
Subtopic
Oncologie

Table of contents

  1. Hepatocellular Carcinoma - Future Outlook
  2. Contents
  3. Preface
  4. Chapter 1 Role of Alleles and Genotypes of Polymorphisms of IL-18 (-607 C/A; and -137 C/G), IFN-γ (+874 A/T) and TNF-α (-238 A/G and -308 A/G) and HLA-G Genes in the Susceptibility of Hepatocellular Carcinoma
  5. Chapter 2 Liver Transplantation for Hepatocellular Carcinoma
  6. Chapter 3 Radioembolization for the Treatment of Unresectable Hepatocellular Carcinoma
  7. Chapter 4 Image-Guided Therapies for Hepatocellular Carcinoma in Hepatocelluar Carcinoma — Future Outlook
  8. Chapter 5 Neoadjuvant Chemotherapy for Hepatocellular Carcinoma
  9. Chapter 6 Targets and Approaches to Control Hepatocellular Carcinoma in Future
  10. Chapter 7 Early Chronic Inflammation and Subsequent Somatic Mutations Shift Phospho-Smad3 Signaling from Tumor- Suppression to Fibro-Carcinogenesis in Human Chronic Liver Diseases
  11. Chapter 8 Surgical Treatment Strategies and Prognosis of Hepatocellular Carcinoma
  12. Chapter 9 Conditions that Predispose to the Development of HCC: The Role of Tumor Associated Fibroblasts and of microRNA
  13. Chapter 10 Signs and Symptoms
  14. Chapter 11 Sorafenib in the Continuum of Care for Hepatocellular Carcinoma: Challenges in Defining Optimal Practice
  15. Chapter 12 Sorafenib-Inhibited Signaling: Emerging Evidence of RAF- Independent Pathways as Potential Therapeutic Targets in Hepatocellular Carcinoma
  16. Chapter 13 Insulin-Like Growth Factor-II: Molecular-Targeted Therapy for Hepatocellular Carcinoma
  17. Chapter 14 Simultaneous Changes in Expression of Bile Canalicular CD10 and Sinusoidal CD105 (Endoglin) in Chronic Hepatitis and Liver Cirrhosis
  18. Chapter 15 Hepatocellular Carcinoma, Steroid Hormones and Metalloproteases